podcasts Ratings /ratings/en/research-insights/podcasts/the-s-p-pharma-dose-episode-26-generic-drug-pricing-when-does-the-pain-stop- content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

In This List

The S&P Pharma Dose - Episode 26: Generic Drug Pricing - When Does the Pain Stop?

COMMENTS

The U.S. Broadcast Radio Sector's Recovery Is Now Set To Drag Into 2022

Fixed Income in 15 – Episode 16

Leveraged Finance & CLOs Uncovered Podcast: EU Could Meet 70% Vaccination Target By Late July If Production Steps Up

COMMENTS

COVID-19 Impact: Key Takeaways From Our Articles

Listen: The S&P Pharma Dose - Episode 26: Generic Drug Pricing - When Does the Pain Stop?

The S&P Pharma Guy, Arthur Wong, shares why generic drug pricing in the U.S., which has been under increasing pressure, should begin to stabilize in 2018. However, the U.S. generic drug environment will likely remain challenging over the near term and S&P harbors longer-term concerns on the industry.

Register with S&P Global Ratings

Register now to access exclusive content, events, tools, and more.

Go Back